Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of chronic and infectious diseases
3.2.1.2 Growing number of blood transfusions
3.2.1.3 Rise in the number of surgical procedures and accidents
3.2.1.4 Increasing number of diagnostic centers and laboratories across the globe
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulations for the disposal of the tubes
3.2.2.2 Risk of contamination and hemolysis
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.5.1 Core technologies
3.5.2 Adjacent technologies
3.6 Future market trends
3.7 Gap analysis
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Serum separating tubes
5.2.1 Silica
5.2.2 Thrombin
5.3 Plasma separation tubes
5.4 EDTA tubes
5.5 Rapid serum tubes
5.6 Coagulation tubes
5.7 Other product types
Chapter 6 Market Estimates and Forecast, By Material, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 PET/Plastic
6.3 Glass
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Serology & immunology
7.3 Blood routine examination
7.4 Coagulation tests
7.5 Genetic studies
7.6 Blood sugar assay
7.7 Other applications
Chapter 8 Market Estimates and Forecast, By End-User, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals & clinics
8.3 Pathology laboratories
8.4 Blood banks
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 AdvaCare Pharma
10.2 Advin Health Care
10.3 Becton, Dickinson and Company
10.4 Biota
10.5 Cardinal Health, Inc.
10.6 Chengdu Rich Science Industry Co., Ltd.
10.7 FL MEDICAL s.r.l.
10.8 Greiner Bio-One International GmbH
10.9 Hindustan Syringes & Medical Devices Ltd
10.10 IntervacTechnology
10.11 MB Plastic Industries
10.12 Poly Medicure Ltd.
10.13 SEKISUI CHEMICAL CO., LTD.
10.14 Streck
10.15 Zhejiang Gongdong Medical Technology Co., Ltd.
